Vivoryon Therapeutics is a therapeutics company; the article does not elaborate on its specific drug programs or markets. The company recently completed a capital raise through a private placement, securing what the article characterizes only as “millions.” This influx of capital is expected to bolster its balance sheet and finance ongoing operations and development work. No details were provided regarding revenue, user metrics, or commercial milestones. The report also omits information on the company’s valuation or cash runway prior to the transaction. Overall, the article focuses almost exclusively on the fact that the firm has raised additional funds.

Total raised

$73M

Funding rounds

3

Latest round

Equity

Latest activity

Jan 2012